Replimune Group Capital Expenditures (CapEx) Growth & History (REPL)

Replimune Group's capital expenditures (capex) was $4.2M for fiscal 2026.

View full Replimune Group company overview

Replimune Group annual capital expenditures (capex) history

Replimune Group annual capital expenditures (capex)

Fiscal yearPeriod endedCapital expenditures (CapEx)ChangeGrowth
20262026-03-31$4.2M−$2.5M−36.85%
20252025-03-31$6.7M$1.0M+18.10%
20242024-03-31$5.7M$3.4M+149.43%
20232023-03-31$2.3M−$66,000−2.83%
20222022-03-31$2.3M−$56,000−2.34%
20212021-03-31$2.4M−$4.1M−63.43%
20202020-03-31$6.5M$3.9M+151.54%
20192019-03-31$2.6M$2.5M+1811.76%
20182018-03-31$136,000−$102,000−42.86%
20172017-03-31$238,000

Replimune Group capital expenditures (capex) trends

Over the last five fiscal years, Replimune Group's capital expenditures (capex) increased from $2.4M to $4.2M, a change of $1.8M. The latest reported quarter, Q1 2027, shows $6,000.

About the metric

What capital expenditures (CapEx) mean

Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.

Calculation and source

SEC-reported capital expenditures

TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Replimune Group source filings ↗

Community posts

It’s quiet here.

No posts about REPL yet. Start the conversation.

Write the first post